Emblem has entered into a five-year delivery contract with Aphria, under which Aphria will supply the emblem at preferential wholesale prices with up to 175,000 kg of high-quality dried cannabis equivalents and crude crude crude oil equivalents. The first deliveries of products to the emblem are expected to begin in May 2019, with an equivalent of 25,000 kg for the remainder of the first year of product delivery. LEAMINGTON, ON, October 8, 2019 /PRNewswire/ – Aphria Inc. (“Aphria” or the “Company”) (TSX: APHA and NYSE: APHA) today issued the following statement regarding the termination of the company`s wholesale contract for cannabis (“agreement”) with Emblem Corp. (“Emblem”),: Aleafia Health (TSX: AH) is paid. He is paid by Aphria Inc (TSX: APHA) (NASDAQ: APHA). The payment is related to a cannabis supply agreement between Emblem and Aphria that was not respected by Aphria. “We are disappointed that Aleafia has decided to terminate its contract with Aphria Inc. The company intended to meet its obligations under the agreement. As a major shareholder in Aleafia, Aphria has made good faith efforts to ensure the continuation of the agreement, as it is in the best interests of all parties involved.
However, the termination of this old contract allows the company to serve its brands, which are in high demand throughout the country. “Aphria`s annual production capacity will reach 255,000 kg by the beginning of 2019, which means that we are well positioned not only to meet all of our supply commitments across Canada and the expected international demand, but also to support the demand expected by our partners,” said Gregg Battersby, vice president of business strategy at Aphria. “We are pleased to support the emblem with a high-quality cannabis offering grown in our Leamington greenhouses, while ensuring healthy revenues and margins for Aphria over the next five years.” TORONTO, September 12, 2018 (GLOBE NEWSWIRE) — Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“emblem” or “company”), through its wholly owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), announced today that it has entered into a five-year wholesale agreement (the “agreement”) with Aphria Inc.